N321 DAVIS ADVANTAGE ASSIGNMENTS FOR FINAL EXAM QUESTIONS WITH COMPLETE ANSWERS.

N321 DAVIS ADVANTAGE
ASSIGNMENTS FOR FINAL EXAM
QUESTIONS WITH COMPLETE
ANSWERS
A ddpatient ddwho ddwas dddiagnosed ddwith ddsystemic ddlupus dderythematosus dd(SLE) dd6
ddmonths ddago ddarrived ddat ddthe ddhospital ddfor dda ddregular ddcheckup. ddThe ddnurse
ddanticipates ddthe ddpriority ddassessment ddwould ddbe ddperforming ddthe ddeye
ddexamination. ddWhich ddmedication ddin ddthe ddtreatment ddleads ddthe ddnurse ddto ddthis
dddecision?


A. ddCapsaicin
B. ddNaproxen
C. ddHydrocodone
D. ddHydroxychloroquine dd- ddAnswer ddD. ddHydroxychloroquine

Which ddis dda ddbiological ddresponse ddmodifier ddused ddto ddtreat ddpatients ddwith
ddsystemic ddlupus dderythematosus dd(SLE)?


A. ddClobetasol
B. ddBelimumab
C. ddAzathioprine
D. ddCyclophosphamide dd- ddAnswer ddB. ddBelimumab

The ddregistered ddnurse ddis ddteaching ddabout ddsystemic ddlupus dderythematosus
dd(SLE). ddWhich ddstatement ddby ddthe ddnurse ddis ddincorrect?


A. dd"It ddis ddimportant ddto ddavoid ddprolonged ddexposure ddto ddsun."
B. dd"It ddis ddimportant ddto ddavoid ddimmunizations ddwith ddlive ddvaccines."
C. dd"It ddis ddimportant ddto ddperform ddvigorous ddexercises ddregularly."
D. dd"If ddyou ddhave dda ddhistory ddof ddphlebitis ddit ddis ddimportant ddto ddavoid ddthe dduse
ddof ddoral ddcontraceptives." dd- ddAnswer ddC. dd"It ddis ddimportant ddto ddperform
ddvigorous ddexercises ddregularly."

, What ddis ddthe ddpurpose ddof ddusing ddan ddechocardiogram ddas dda dddiagnostic ddtool
ddin dda ddpatient ddwith ddsystemic ddlupus dderythematosus dd(SLE)?


A. ddTo ddassess ddfor ddpericardial ddinvolvement ddand ddelevated ddpulmonary ddartery
ddpressure
B. ddTo ddaccess ddneurological dddefects ddand ddcognitive dddysfunction
C. ddTo ddassess ddthe ddkidney ddsize ddif ddthere ddis ddany ddsign ddof ddrenal ddimpairment
D. ddTo ddassess ddjoint ddpain, ddswelling, ddand ddstiffness dd- ddAnswer ddA. ddTo ddassess
ddfor ddpericardial ddinvolvement ddand ddelevated ddpulmonary ddartery ddpressure


Which ddconditions ddare ddtreated ddwith ddhigh dddose ddoral ddglucocorticoids ddin dda
ddpatient ddwith ddsystemic ddlupus dderythematosus dd(SLE)? dd(Select ddall ddthat ddapply.)


A. ddOral ddand ddnasal ddulcers
B. ddPneumonitis
C. ddChronic ddcutaneous ddlupus
D. ddSystemic ddvasculitis
E. ddHematologic ddabnormalities dd- ddAnswer ddB. ddPneumonitis
D. ddSystemic ddvasculitis
E. ddHematologic ddabnormalities

Which dddiagnostic ddtool ddis ddmost ddlikely ddused ddto ddassess ddfor ddjoint dddamage ddin
ddan ddolder ddadult ddwith ddsystemic ddlupus dderythematosus dd(SLE)?


A. ddUltrasound
B. ddComputed ddtomography dd(CT)
C. ddX-ray
D. ddMagnetic ddresonance ddimaging dd(MRI) dd- ddAnswer ddC. ddX-ray

A ddregistered ddnurse ddis ddteaching ddabout ddcyclophosphamide ddtreatment ddin
ddpatients ddwith ddsystemic ddlupus dderythematosus. ddWhich ddcomplication ddor
dddisease ddindicates dda ddneed ddfor ddfurther ddteaching?


A. ddLupus ddnephritis
B. ddPulmonary ddhemorrhage
C. ddPneumonitis
D. ddSystemic ddvasculitis dd- ddAnswer ddC. ddPneumonitis

A ddnurse ddis ddeducating ddabout ddthe ddmedications ddthat ddcan ddbe ddadministered ddto
dda ddpatient ddwith ddlupus. ddWhich ddstatement ddindicates dda ddneed ddfor ddfurther
ddteaching?


A. ddHydroxychloroquine
B. ddGlucocorticoids
C. ddOral ddcontraceptives
D. ddMethotrexate dd- ddAnswer ddC. ddOral ddcontraceptives